Probiotic (VSL#3)	Placebo	Fasting blood glucose	15396	15566	Fasting blood glucose (FBG) rose slightly in the placebo group but reduced significantly (P < 0.05) in the probiotic, omega-3, and probiotic + omega-3 combination groups.
Probiotic (VSL#3)	Placebo	Lipid profile improvement	14692	14851	In the probiotic group HDL increased by 18.5% (P < 0.01); LDL (P < 0.05), triglycerides, and VLDL (P < 0.01) decreased by 7.04%, 5.8%, and 12.98%, respectively
Omega-3	Placebo	Lipid profile improvement	14863	14993	In the omega-3 group, total cholesterol, triglycerides, LDL, and VLDL decreased and HDL increased significantly by 6.7% (P < 0.01)
Omega-3	Placebo	Fasting blood glucose	15396	15566	Fasting blood glucose (FBG) rose slightly in the placebo group but reduced significantly (P < 0.05) in the probiotic, omega-3, and probiotic + omega-3 combination groups.
Probiotic (VSL#3)	Placebo	Lipid profile improvement	711	866	The probiotic (VSL#3) supplemented group had significant reduction in total cholesterol, triglyceride, LDL, and VLDL and had increased HDL (P < 0.05) value
Omega-3	Placebo	Lipid profile improvement	14863	15185	In the omega-3 group, total cholesterol, triglycerides, LDL, and VLDL decreased and HDL increased significantly by 6.7% (P < 0.01). HDL increased by 23.2% and LDL decreased by 10.7%; triglycerides decreased by 7.78% and VLDL by 7.78% (P < 0.01) in the probiotic with omega-3 group, compared with baseline levels (Table 1).
Omega-3	Placebo	Atherogenic Index	16887	16994	Atherogenic index was significantly (P < 0.01) decreased in the probiotic, omega-3, and combination groups.
Probiotic (VSL#3)	Placebo	Atherogenic Index	16887	16994	Atherogenic index was significantly (P < 0.01) decreased in the probiotic, omega-3, and combination groups.
